Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab

Author：                  

Publisher： Spandidos Publications

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.4, Iss.1, 2012-01, pp. : 151-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Sequential Radiochemotherapy in Preirradiated Malignant Gliomas in a Phase II Study

By Schäfer Ulrich   Micke Oliver   Schüller Patrick   Schuck Andreas   Willich Normann  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 233-239

Springer Publishing Company

Access to resources Recommend Favorite

A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors

By Okamoto Wataru   Yoshino Takayuki   Takahashi Toshiaki   Okamoto Isamu   Ueda Shinya   Tsuya Asuka   Boku Narikazu   Nishio Kazuto   Fukuoka Masahiro   Yamamoto Nobuyuki   Nakagawa Kazuhiko  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1063-1071

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy

By Bebb Gwyn   Smith Colum   Rorke Stewart   Boland William   Nicacio Leonardo   Sukhoo Ryan   Brade Anthony  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 837-845

Springer Publishing Company

Access to resources Recommend Favorite

Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: A hellenic cooperative oncology group phase III study

By Fountzilas George   Ciuleanu Elisabeta   Dafni Urania   Plataniotis George   Kalogera-Fountzila Anna   Samantas Epaminontas   Athanassiou Eleni   Tzitzikas John   Ciuleanu Tudor   Nikolaou Angelos   Pantelakos Panayiotis   Zaraboukas Thomas   Zamboglou Nikolaos   Daniilidis John   Ghilezan Nicolas  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 95-107

Humana Press, Inc

Access to resources Recommend Favorite

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas

By Desjardins Annick   Quinn Jennifer   Vredenburgh James   Sathornsumetee Sith   Friedman Allan   Herndon James   McLendon Roger   Provenzale James   Rich Jeremy   Sampson John   Gururangan Sridharan   Dowell Jeannette   Salvado August   Friedman Henry   Reardon David  

Journal of Neuro-Oncology, Vol. 83, Iss. 1, 2007-05 ,pp. : 53-60

Springer Publishing Company

Access to resources Recommend Favorite